Last updated on December 2018

Assessment of Treatment Patterns of Severe Asthmatic Patients Across the Gulf Region - SevEos Study

Brief description of study

SevEos is a cross-sectional, multi-center, non-interventional study aimed to describe the treatment patterns in 250 severe asthma patients across the Gulf region. In addition, the study will determine the current level of asthma control and quality of life in these patients; describe the exacerbation patterns; and determine the current levels of blood eosinophils for the enrolled patients.

Detailed Study Description

The primary objective of this study is to describe the treatments patterns of severe asthmatic patients across four Gulf countries during the past year.

Secondary Objectives

  1. To determine the current level of asthma control in these patients. In addition, a comparison of uncontrolled asthma between those with a eosinophilic count 300 cell/l and those with an elevated eosinophilic count less than that.
  2. To determine the current and past year levels of blood eosinophils, and the percentage of patients with elevated eosinophilic level 150 cells/L and 300 cells/L
  3. To describe the frequency of exacerbations during the past year.
  4. To assess the current quality of life (QoL) of these patients.
  5. To determine the past year levels of serum IgE.
  6. Exploratory objective: To determine the past year levels of other inflammatory biomarkers like periostin and fraction of exhaled nitric oxide (FeNO).

Clinical Study Identifier: NCT03387722

Contact Investigators or Research Sites near you

Start Over

AstraZeneca Clinical Study Information Center

Rashid Hospital
Dubai, United Arab Emirates
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.